AI English summary of an SEC filing — figures as filed

Medtronic said Gregory L. Smith, Executive Vice President, Enterprise Operations, notified the company on November 1, 2025 of his decision to retire, effective December 2, 2025.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Nov 3, 2025Period of report Nov 1, 2025Summary published (UTC) Oct 12, 2026

Key points

AI summary

Medtronic said Gregory L. Smith, Executive Vice President, Enterprise Operations, notified the company on November 1, 2025 of his decision to retire, effective December 2, 2025.
The company said Smith decided to retire from the company and join a private equity-held organization.
Medtronic said Smith will be eligible for retirement treatment of his outstanding equity compensation as disclosed in the company's annual definitive proxy statement filed on August 25, 2025, as of December 2, 2025.
The company said retirement treatment of equity includes acceleration of unvested stock options and continued vesting of restricted stock units (RSUs) and performance stock units (PSUs) consistent with the forms of those equity award agreements publicly filed with the U.S. Securities and Exchange Commission.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Gregory L. Smith Retirement Notification

Medtronic said Gregory L. Smith, Executive Vice President, Enterprise Operations, notified the company on November 1, 2025 of his decision to retire, effective December 2, 2025.

Source · Based on the filing body and exhibits

Post-Retirement Career Move

The company said Smith decided to retire from the company and join a private equity-held organization.

Source · Based on the filing body and exhibits

Eligibility for Equity Compensation Retirement Treatment

Medtronic said Smith will be eligible for retirement treatment of his outstanding equity compensation as disclosed in the company's annual definitive proxy statement filed on August 25, 2025, as of December 2, 2025.

Source · Based on the filing body and exhibits

Details of Retirement Treatment

The company said retirement treatment of equity includes acceleration of unvested stock options and continued vesting of restricted stock units (RSUs) and performance stock units (PSUs) consistent with the forms of those equity award agreements publicly filed with the U.S. Securities and Exchange Commission.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.